Snowball logo
logo
4521

Kaken Pharmaceutical Co Ltd

4521 TSE
¥4,015.00-¥25.00  (0.62%)
💡 Click on a row in the table to make it appear on the graph
📊 Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20222023202420252026TTM
Revenue
Total revenue
76,03472,98472,04494,03576,87176,871
COGS
34,45833,42833,50535,77337,63136,879
Gross Profit
41,57639,55638,53958,26239,24039,992
Operating Expenses & Income
Operating Income
17,0647,9989,51321,036(899)(899)
Total Operating Expenses
24,50831,55329,02637,22640,13940,891
R&D Expenses
8,42015,78912,54318,72520,58520,585
Selling General & Admin Expenses
15,83315,47631---
Earnings from Continuing Operations
Interest Expense
(17)(17)(17)(28)(45)(45)
Interest Income
349395877275-
Income Tax Expense
4,3361,3771,7705,490168168
Net Income
Net Income
9,5495,4408,02513,9452,1442,144
Supplemental
EBIT
13,9036,8349,81619,4662,3582,360
EBITDA
16,3849,40212,56922,0205,6835,685
In millions of JPY, except % and values per 1 share